Hypophysitis related to immune checkpoint inhibitors: An intriguing adverse event with many faces.

导出 LinkOut

翻译打印收藏纠错

作者： Maria V,Deligiorgi ^[1] ; Charis,Liapi ^[1] ; Dimitrios T,Trafalis ^[1]

作者单位： Department of Pharmacology-Clinical Pharmacology Unit, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece. ^[1]

关键词 Anti-CTLA-4 monoclonal antibodies anti-PD-L1 monoclonal antibodies anti-PD1 monoclonal antibodies immune-checkpoint inhibitors immune-related central diabetes insipidus immune-related hypophysitis immune-related isolated ACTH deficiency

主题词抗体, 单克隆(Antibodies, Monoclonal);人类(Humans);免疫疗法(Immunotherapy);肿瘤(Neoplasms)

DOI 10.1080/14712598.2021.1869211

PMID 33393372

发布时间 2022-01-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Expert opinion on biological therapy

2021年21卷8期

1097-1120页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Hypophysitis related to immune checkpoint inhibitors: An intriguing adverse event with many faces.

Expert opinion on biological therapy

相似文献

Expert opinion on biological therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hypophysitis related to immune checkpoint inhibitors: An intriguing adverse event with many faces.

Expert opinion on biological therapy

相似文献

Expert opinion on biological therapy

相关期刊

检索历史清除